Listed

Enveric Biosciences, Inc.: Form 10-Q for the period ended Jun 30, 2011

Filed with the SEC on Aug 2, 2011 and accepted by EDGAR at Aug 2, 2011, 15:02 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2011-04-01 to 2011-06-30$0us-gaap:CostOfRevenue
Cost of revenue6 months2011-01-01 to 2011-06-30$0us-gaap:CostOfRevenue
Gross profit3 months2011-04-01 to 2011-06-30$0us-gaap:GrossProfit
Gross profit6 months2011-01-01 to 2011-06-30$0us-gaap:GrossProfit
Research and development3 months2011-04-01 to 2011-06-30$0us-gaap:ResearchAndDevelopmentExpense
Research and development6 months2011-01-01 to 2011-06-30$0us-gaap:ResearchAndDevelopmentExpense
Operating income3 months2011-04-01 to 2011-06-30−$3.6kus-gaap:OperatingIncomeLoss
Operating income6 months2011-01-01 to 2011-06-30−$14.7kus-gaap:OperatingIncomeLoss
Interest expense3 months2011-04-01 to 2011-06-30$0us-gaap:InterestExpense
Interest expense6 months2011-01-01 to 2011-06-30$0us-gaap:InterestExpense
Income tax3 months2011-04-01 to 2011-06-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax6 months2011-01-01 to 2011-06-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2011-04-01 to 2011-06-30−$3.6kus-gaap:NetIncomeLoss
Net income6 months2011-01-01 to 2011-06-30−$14.7kus-gaap:NetIncomeLoss
Diluted EPS3 months2011-04-01 to 2011-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2011-01-01 to 2011-06-30$2.7kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2011-06-30$3.8kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-06-30$3.1kus-gaap:AssetsCurrent
Total assetsAt period end2011-06-30$8.1kus-gaap:Assets
Current liabilitiesAt period end2011-06-30$72.3kus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2011-06-30−$64.2kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001477932-11-001265. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.